Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 16Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Non-Hodgkin 10Lymphoma 9Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia 8Recurrence 6Hodgkin Disease 6Myeloproliferative Disorders 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Neoplasms 4Neoplasm, Residual 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Lymphoid 4Immunoproliferative Disorders 4Immune System Diseases 4Burkitt Lymphoma 4Precancerous Conditions 3Lymphoproliferative Disorders 3Lymphoma, B-Cell, Marginal Zone 3Lymphatic Diseases 3Leukemia, Myelomonocytic, Chronic 3

Interventions

haloperidol decanoate 1fludarabine phosphate 1fludarabine 1Temozolomide 1Surveys and Questionnaires 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Lorazepam 1Dexamethasone 1Cyclophosphamide 1Bendamustine Hydrochloride 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neurotoxicity Syndromes × fludarabine phosphate × Clear all
NCT03696784 2025-12-08

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Active not recruiting
19 enrolled
Lymphoid

Cytokine Release Syndrome, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, B-Cell, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡